HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMassachusetts General Hospital
About this trial
This research study is evaluating a program that entails a healthcare at home intervention for people with advanced liver disease.
Eligibility criteria
Qualifiers
Adult patients ≥ 18 years old with diagnosis of cirrhosis based on histology, radiology, and/or elastography presenting to the emergency department or inpatient general medicine service
Ascites (requiring diuretics or serial large volume paracenteses)
Hepatic hydrothorax (requiring diuretics)
Hepatic encephalopathy (requiring medications)
Disqualifiers
History of solid organ transplantation
On hemodialysis
MELD score > 20
Score <10 on Simplified Animal Naming Test (S-ANT1)
Trial design
Treatments tested in this trial
- Hepatology Home Hospital
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov